Effects of psychoactive drugs on cellular bioenergetic pathways

References

• Andreazza AC, Shao L, Wang JF, Young LT. 2010. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry. 67(4):360–368.
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Wang JF, Salmasi F, Shao L, Young LT. 2013. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J Neurochem. 127(4):552–561.
   PubMed Web of Science ®Google Scholar
• Bachmann RF, Wang Y, Yuan P, Zhou R, Li X, Alesci S, Du J, Manji HK. 2009. Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamine-induced mitochondrial damage. Int J Neuropsychopharm. 12(06):805–822.
   PubMed Web of Science ®Google Scholar
• Baxter LR, Jr, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE, Gerner RH, Sumida RM. 1989. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiatry. 46(3):243–250.
   PubMed Web of Science ®Google Scholar
• Bazinet RP, Layé S. 2014. Polyunsaturated fatty acids and their metabolites in brain function and disease. Nat Rev Neurosci. 15(12):771–785.
   PubMed Web of Science ®Google Scholar
• Beech RD, Lowthert L, Leffert JJ, Mason PN, Taylor MM, Umlauf S, Lin A, Lee JY, Maloney K, Muralidharan A, et al. 2010. Increased peripheral blood expression of electron transport chain genes in bipolar depression. Bipolar Disord. 12(8):813–824.
   PubMed Web of Science ®Google Scholar
• Ben-Shachar D. 2017. Mitochondrial multifaceted dysfunction in schizophrenia; complex I as a possible pathological target. Schizophr Res. 187:3–10.
   PubMed Web of Science ®Google Scholar
• Berk M, Turner A, Malhi GS, Ng CH, Cotton SM, Dodd S, Samuni Y, Tanious M, McAulay C, Dowling N, et al. 2019. A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo. BMC Med. 17(1):18
   PubMed Web of Science ®Google Scholar
• Bolger AM, Lohse M, Usadel B. 2014. Trimmomatic: a flexible trimmer for illumina sequence data. Bioinformatics. 30(15):2114–2120.
   PubMed Web of Science ®Google Scholar
• Bortolasci CC, Spolding B, Callaly E, Martin S, Panizzutti B, Kidnapillai S, Connor T, Hasebe K, Mohebbi M, Dean OM, et al. 2018. Mechanisms underpinning the polypharmacy effects of medications in psychiatry. Int J Neuropsychopharmacol. 21(6):582–591.
   PubMed Web of Science ®Google Scholar
• Bubber P, Hartounian V, Gibson GE, Blass JP. 2011. Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients. Eur Neuropsychopharmacol. 21(3):254–260.
   PubMed Web of Science ®Google Scholar
• Cataldo AM, McPhie DL, Lange NT, Punzell S, Elmiligy S, Ye NZ, Froimowitz MP, Hassinger LC, Menesale EB, Sargent LW, et al. 2010. Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am J Pathol. 177(2):575–585.,
   PubMed Web of Science ®Google Scholar
• Cikánková T, Fišar Z, Bakhouche Y, Ľupták M, Hroudová J. 2019. In vitro effects of antipsychotics on mitochondrial respiration. Naunyn Schmiedebergs Arch Pharmacol. 392(10):1209–1223. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF. 2004. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry. 61(5):450–458.
   PubMed Web of Science ®Google Scholar
• de Sousa RT, Streck EL, Zanetti MV, Ferreira GK, Diniz BS, Brunoni AR, Busatto GF, Gattaz WF, Machado-Vieira R. 2015. Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes. Psychopharmacology. 232(1):245–250.
   PubMed Web of Science ®Google Scholar
• Divakaruni AS, Paradyse A, Ferrick DA, Murphy AN, Jastroch M. 2014. Analysis and interpretation of microplate-based oxygen consumption and pH data. Meth Enzymol. 547:309–354.
   PubMed Web of Science ®Google Scholar
• Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. 2013. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 29(1):15–21.
   PubMed Web of Science ®Google Scholar
• Dogan AE, Yuksel C, Du F, Chouinard VA, Öngür D. 2018. Brain lactate and pH in schizophrenia and bipolar disorder: a systematic review of findings from magnetic resonance studies. Neuropsychopharmacol. 43(8):1681–1690.
   PubMed Web of Science ®Google Scholar
• Fattal O, Link J, Quinn K, Cohen BH, Franco K. 2007. Psychiatric comorbidity in 36 adults with mitochondrial cytopathies. CNS Spectr. 12(6):429–438.
   PubMed Web of Science ®Google Scholar
• Forester BP, Harper DG, Jensen JE, Ravichandran C, Jordan B, Renshaw PF, Cohen BM. 2009. 31Phosphorus magnetic resonance spectroscopy study of tissue specific changes in high energy phosphates before and after sertraline treatment of geriatric depression. Int J Geriat Psychiatry. 24(8):788–797.
   PubMed Web of Science ®Google Scholar
• Gardner A, Johansson A, Wibom R, Nennesmo I, von Döbeln U, Hagenfeldt L. 2003. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J Affect Disord. 76(1–3):55–68.
   PubMed Web of Science ®Google Scholar
• Haas R, Chir B, Stumpf DA, Parks JK, Eguren L. 1981. Inhibitory effects of sodium valproate on oxidative phosphorylation. Neurology. 31(11):1473–1476.
   PubMed Web of Science ®Google Scholar
• Haile Y, Fu W, Shi B, Westaway D, Baker G, Jhamandas J, Giuliani F. 2014. Characterization of the NT2-derived neuronal and astrocytic cell lines as alternative in vitro models for primary human neurons and astrocytes. J Neurosci Res. 92(9):1187–1198.
   PubMed Web of Science ®Google Scholar
• Hayasaka K, Takahashi I, Kobayashi Y, Iinuma K, Narisawa K, Tada K. 1986. Effects of valproate on biogenesis and function of liver mitochondria. Neurology. 36(3):351–356.
   PubMed Web of Science ®Google Scholar
• Hosokawa T, Momose T, Kasai K. 2009. Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states. Prog Neuropsychopharmacol Biol Psychiatry. 33(2):243–250.
   PubMed Web of Science ®Google Scholar
• Ignácio ZM, Réus GZ1, Abelaira HM, Titus SE, Carlessi AS, da Luz JR, Matias BI, Bruchchen L, Carvalho-Silva M, Gomes LM, et al. 2015. Acute and chronic treatments with quetiapine increase mitochondrial respiratory chain complex activity in the rat brain. Curr Neurovasc Res. 12(3):283–292.
   PubMed Web of Science ®Google Scholar
• Iwamoto K, Bundo M, Kato T. 2005. Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet. 14(2):241–253.
   PubMed Web of Science ®Google Scholar
• Ji B, La Y, Gao L, Zhu H, Tian N, Zhang M, Yang Y, Zhao X, Tang R, Ma G, et al. 2009. A comparative proteomics analysis of rat mitochondria from the cerebral cortex and hippocampus in response to antipsychotic medications. J Proteome Res. 8(7):3633–3641.
   PubMed Web of Science ®Google Scholar
• Karabatsiakis A, Böck C, Salinas-Manrique J, Kolassa S, Calzia E, Dietrich DE, Kolassa I-T. 2014. Mitochondrial respiration in peripheral blood mononuclearcells correlates with depressive subsymptoms and severity of major depression. Transl Psychiatry. 4(6):e397–e397.
   PubMed Web of Science ®Google Scholar
• Kato T. 2008. Role of mitochondrial DNA in calcium signaling abnormality in bipolar disorder. Cell Calcium. 44(1):92–102.
   PubMed Web of Science ®Google Scholar
• Kato T, Inubushi T, Kato N. 1998. Magnetic resonance spectroscopy in affective disorders. J Neuropsychiatry Clin Neurosci . 10(2):133–147.
   PubMed Web of Science ®Google Scholar
• Kato T, Kato N. 2000. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord. 2(3):180–190.
   PubMed Web of Science ®Google Scholar
• Kim HK, Andreazza AC, Elmi N, Chen W, Young LT. 2016. Nod-like receptor pyrin containing 3 (NLRP3) in the post-mortem frontal cortex from patients with bipolar disorder: a potential mediator between mitochondria and immune-activation. J Psychiatr Res. 72:43–50.
   PubMed Web of Science ®Google Scholar
• Koene S, Kozicz TL, Rodenburg RJT, Verhaak CM, de Vries MC, Wortmann S, van de Heuvel L, Smeitink JAM, Morava E. 2009. Major depression in adolescent children consecutively diagnosed with mitochondrial disorder. J Affect Disord. 114(1–3):327–332.
   PubMed Web of Science ®Google Scholar
• Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S. 2004. Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry. 61(3):300–308.
   PubMed Web of Science ®Google Scholar
• Kuang H, Duong A, Jeong H, Zachos K, Andreazza AC. 2018. Lactate in bipolar disorder: a systematic review and meta-analysis. Psychiatry Clin Neurosci. 72(8):546–555.
   PubMed Web of Science ®Google Scholar
• Manatt M. 2011. The effects of mitochondrial dysfunction in schizophrenia. J Med Genet Genom. 3:84–94.
   Google Scholar
• Martin SD, Morrison S, Konstantopoulos N, McGee SL. 2014. Mitochondrial dysfunction has divergent, cell type-dependent effects on insulin action. Mol Metab. 3(4):408–418.
   PubMed Web of Science ®Google Scholar
• Maurer IC, Schippel P, Volz HP. 2009. Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue. Bipolar Disord. 11(5):515–522.
   PubMed Web of Science ®Google Scholar
• McGee SL, Sadli N, Morrison S, Swinton C, Suphioglu C. 2011. DHA protects against zinc mediated alterations in neuronal cellular bioenergetics. Cell Physiol Biochem. 28(1):157–162.
   PubMedGoogle Scholar
• Moore CM, Christensen JD, Lafer B, Fava M, Renshaw PF. 1997. Lower levels of nucleoside triphosphate in the basal ganglia of depressed subjects: a phosphorous-31 magnetic resonance spectroscopy study. Am J Psychiatry. 154(1):116–118.
   PubMed Web of Science ®Google Scholar
• Morava E, Gardeitchik T, Kozicz T, de Boer L, Koene S, de Vries MC, McFarland R, Roobol T, Rodenburg RJT, Verhaak CM. 2010. Depressive behaviour in children diagnosed with a mitochondrial disorder. Mitochondrion. 10(5):528–533.
   PubMed Web of Science ®Google Scholar
• Morris G, Walder K, McGee SL, Dean OM, Tye SJ, Maes M, Berk M. 2017. A model of the mitochondrial basis of bipolar disorder. Neurosci Biobehav Rev. 74:1–20.
   PubMed Web of Science ®Google Scholar
• Naydenov AV, MacDonald ML, Ongur D, Konradi C. 2007. Differences in lymphocyte electron transport gene expression levels between subjects with bipolar disorder and normal controls in response to glucose deprivation stress. Arch Gen Psychiatry. 64(5):555–564.
   PubMed Web of Science ®Google Scholar
• Pereira C, Chavarria V, Vian J, Ashton MM, Berk M, Marx W, Dean OM. 2018. Mitochondrial agents for bipolar disorder. Int J Neuropsychopharmacol. 21(6):550–569.
   PubMed Web of Science ®Google Scholar
• Perica MM, Delas I. 2011. Essential fatty acids and psychiatric disorders. Nutr Clin Pract. 26(4):409–425.
   Google Scholar
• Ponchaut S, van Hoof F, Veitch K. 1992a. Cytochrome aa3 depletion is the cause of the deficient mitochondrial respiration induced by chronic valproate administration. Biochem Pharmacol. 43(3):644–647.
   PubMed Web of Science ®Google Scholar
• Ponchaut S, van Hoof F, Veitch K. 1992b. In vitro effects of valproate and valproate metabolites on mitochondrial oxidations. Biochem Pharmacol. 43(11):2435–2445.
   PubMed Web of Science ®Google Scholar
• R Core Team. 2014. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org/.
   Google Scholar
• Rajasekaran A, Venkatasubramanian G, Berk M, Debnath M. 2015. Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications. Neurosci Biobehav Rev. 48:10–21.
   PubMed Web of Science ®Google Scholar
• Regenold WT, Phatak P, Marano CM, Sassan A, Conley RR, Kling MA. 2009. Elevated cerebrospinal fluid lactate concentrations in patients with bipolar disorder and schizophrenia: implications for the mitochondrial dysfunction hypothesis. Biol Psychiatry. 65(6):489–494.
   PubMed Web of Science ®Google Scholar
• Robinson MD, McCarthy DJ, Smyth GK. 2010. EdgeR: a bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 26(1):139–140.
   PubMed Web of Science ®Google Scholar
• Scaini G, Quevedo J, Velligan D, Roberts DL, Raventos H, Walss-Bass C. 2018. Second generation antipsychotic-induced mitochondrial alterations: implications for increased risk of metabolic syndrome in patients with schizophrenia. Eur Neuropsychopharmacol. 28(3):369–380.
   PubMed Web of Science ®Google Scholar
• Smits BW, Fermont J, Delnooz CC, Kalkman JS, Bleijenberg G, van Engelen BG. 2011. Disease impact in chronic progressive external ophthalmoplegia: more than meets the eye. Neuromuscul Disord. 21(4):272–278.
   PubMed Web of Science ®Google Scholar
• Stork C, Renshaw PF. 2005. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry. 10(10):900–919.
   PubMed Web of Science ®Google Scholar
• Sun X, Wang JF, Tseng M, Young LT. 2006. Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatry Neurosci. 31(3):189–196.
   PubMed Web of Science ®Google Scholar
• Vawter MP, Tomita H, Meng F, Bolstad B, Li J, Evans S, Choudary P, Atz M, Shao L, Neal C, et al. 2006. Mitochondrial‐related gene expression changes are sensitive to agonal‐pH state: implications for brain disorders. Mol Psychiatry. 11(7):663–679.
   Web of Science ®Google Scholar
• Volz H-P, Rzanny R, Riehemann S, May S, Hegewald H, Preussler B, Hübner G, Kaiser WA, Sauer H. 1998. 31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients. Eur Arch Psychiatry Clin Neurosci. 248(6):289–295.
   PubMed Web of Science ®Google Scholar
• Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, Sharma V, Goldstein BI, Rej S, Beaulieu S, et al. 2018. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 20(2):97–170.
   PubMed Web of Science ®Google Scholar
• Yoshimi N, Futamura T, Kakumoto K, Salehi AM, Sellgren CM, Holmén-Larsson J, Jakobsson J, Pålsson E, Landén M, Hashimoto K. 2016. Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder. BBA Clin. 5(1):151–158.
   PubMedGoogle Scholar